Allogene Therapeutics ALLO
NASDAQ ALLO
$1.62 -0.01 (-0.61%)
At close: Sep 29, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Operating Expenses (2018 - 2026)

Updated

Allogene Therapeutics (ALLO) recorded Operating Expenses of $51.56 million in Q2 2026, down 9.3% from $56.82 million a year earlier but up 11.9% from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Operating Expenses (2018 - 2026) Analysis & Trends

On a TTM basis, Allogene Therapeutics' Operating Expenses came in at $184.96 million as of Jun 30, 2026, down 27.3% year-over-year; for FY2025, it came in at $209.32 million, down 23.4% from FY2024.

  • Annual Operating Expenses has declined for three straight years, with a five-year compound annual growth rate of -4.1% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $273.22 million in FY2024 (-16.7%), $327.83 million in FY2023 (-2.3%), $335.69 million in FY2022 (+14.1%) and $294.28 million in FY2021 (+14.0%).
  • Quarterly Operating Expenses has ranged from $42.4 million in Q4 2025 to $99.12 million in Q1 2023 over the past five years.
  • On a year-over-year basis, Operating Expenses has declined for seven consecutive quarters, with an average decline of 18.5% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 30.4% in Q4 2022, against a decline of 37.4% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $46.09 million (Q1 2026), $42.4 million (Q4 2025) and $44.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Allogene Therapeutics 562.91 Mn 562.91 Mn - 51.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.56 Mn
Mar 31, 2026 46.09 Mn
Dec 31, 2025 42.40 Mn
Sep 30, 2025 44.90 Mn
Jun 30, 2025 56.82 Mn
Mar 31, 2025 65.19 Mn
Dec 31, 2024 60.49 Mn
Sep 30, 2024 71.77 Mn
Jun 30, 2024 71.43 Mn
Mar 31, 2024 69.53 Mn
Dec 31, 2023 85.13 Mn
Sep 30, 2023 63.02 Mn
Jun 30, 2023 80.56 Mn
Mar 31, 2023 99.12 Mn
Dec 31, 2022 96.42 Mn
Sep 30, 2022 82.54 Mn
Jun 30, 2022 76.68 Mn
Mar 31, 2022 80.05 Mn
Dec 31, 2021 73.94 Mn
Sep 30, 2021 77.72 Mn
API Access

Allogene Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ALLO&period=max&api_key=YOUR_API_KEY